Clinical Trial Update: A Phase II Study of TPF With PD-1 Inhibitor Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase II study evaluating TPF chemotherapy with a PD-1 inhibitor as induction therapy for locally advanced nasopharyngeal carcinoma; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• PD-1 inhibitor

Snippet

Sponsor: Weiwei Zhang | Conditions: TPF, Immunotherapy | Phase 2 | Status: NOT_YET_RECRUITING